First-Line Atezolizumab Plus Chemotherapy in Elderly Patients With Advanced NSCLC, IFCT-1805 Elderly: A Randomized, Multicenter, Phase 3 Trial

  • Etude concernée: IFCT-1805
  • Auteurs / Authors: C. Mascaux; L. Greillier; L. Moreau; T. Egenod; A-C. Toffart; J. Cadranel; A. Stancu; O. Molinier; M. Wislez; S. Fraboulet; E. Giroux-Leprieur; E. Pichon; L. Bigay-Game; N. Cloarec; S. Couraud; P. Masson; A. Langlais; F. Morin; E. Quoix; V. Westeel
  • Journal / Conference: WCLC
  • Année / Year: 2025
  • PMID: Oral abstract